Eurogentec

Executive Summary

Eurogentec is a well-established Belgian CDMO with over 35 years of experience in manufacturing critical biologics, including oligonucleotides, plasmids, recombinant proteins, and mRNA. The company operates GMP-accredited facilities and supports clients from preclinical development through commercialization. As the demand for mRNA and oligonucleotide therapeutics grows, Eurogentec is well-positioned to benefit from increasing outsourcing by pharma and biotech firms. Its strong track record and diverse service offering, spanning research to commercial production, underpin a stable revenue base and potential for expansion.

Upcoming Catalysts (preview)

• Q3 2026Expansion of mRNA manufacturing capacity75% success
• Q4 2026Major CDMO contract win with a top pharma company60% success
• Q2 2026Strategic partnership for oligonucleotide therapeutics65% success